IV drug trial offers hope for untreatable facial pain
NCT ID NCT07250984
Summary
This study is testing whether an intravenous (IV) medication called eptinezumab can help reduce severe facial pain that hasn't responded to other treatments. It will involve 10 people with conditions like trigeminal neuralgia or burning mouth syndrome. Researchers will give the drug by IV and measure changes in pain levels and quality of life over three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pain Therapy Clinic of University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.